Berinert
Berinert is used to prevent recurrent attacks of hereditary angioedema (HAE) in teenagers and adults.
Form
injektiokuiva-aine ja liuotin, liuosta varten
Strength
3000 IU
Active Ingredient
C1 esterase inhibitor
Manufacturer
CSL Behring GmbH
How to Use
Dosage
The recommended dose is 60 IU per kilogram of body weight.
Method
Berinert is given as an injection under the skin.
Important
The recommended dose is 60 IU per kilogram of body weight. No other maximum daily dose is specified.
Possible Side Effects
COMMON
- •Reactions at the injection site, such as bruising, cold sensation, redness, bleeding, swelling, pain, itching, rash, and warmth.
- •Nasopharyngitis (runny or stuffy nose, sneezing, watery eyes).
RARE
- •Hypersensitivity or allergic reactions, such as itching, rash, and hives.
- •Dizziness.
Important Warnings
- Do not use Berinert if you have had a life-threatening allergic reaction (anaphylaxis) to the protein C1-esterase inhibitor or any other ingredient in this medicine. If you have a severe allergic reaction during treatment, stop the medicine right away.
- Tell your doctor if you have had blood clot problems, heart or blood vessel disease, a stroke, thick blood, a catheter in your veins, or have been immobile for a long time. Certain medications (like birth control pills) can also increase this risk.
- Do not mix Berinert with other medicines or diluents in the same syringe.
- If you are pregnant, breastfeeding, or planning to have a baby, ask your doctor for advice before using this medicine.